Impact of RIVP on GI Function in Patients Undergoing Surgical Repair for ATAAD
NCT06434987 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2024-05-30
Summary
Acute Type A Aortic Dissection (ATAAD) is a serious medical condition that requires immediate surgical intervention. The repair of Acute Type A Aortic Dissection (ATAAD) combines different surgical procedures, including the use of Cardiopulmonary Bypass (CPB). This study focuses on the gastrointestinal (GI) system and the complications arising in the gastrointestinal (GI) system as a result of this procedure. Retrograde Inferior Vena Cava Perfusion (RIVP) is a technique used during Cardiopulmonary Bypass (CPB) that could show potential in mitigating latent gastrointestinal (GI) complications. The study aims to evaluate the effectiveness of Retrograde Inferior Vena Cava Perfusion (RIVP) in patients receiving Acute Type A Aortic Dissection (ATAAD) repair with Cardiopulmonary Bypass (CPB) in reducing Ischemic Reperfusion (IR) injury and inflammatory responses that affect gastrointestinal (GI) integrity. It intends to compare the postoperative gastrointestinal (GI) complications and long-term gastrointestinal (GI) function between patients treated with Antegrade Cerebral Perfusion (ACP) and Retrograde Inferior Vena Cava Perfusion (RIVP), and those treated with Antegrade Cerebral Perfusion (ACP) alone. The patients will be placed in their respective groups as per the decision of the surgeons, perfusionists, and the condition of the patient. Data collection will be facilitated by a comprehensive Case Report Form (CRF). This pilot study, guided by established methodologies, places the study's sample size at 30 to ensure statistical reliability and prevent resource wastage. Through this approach of sample collection, baseline data collection, peri-operative data recording, and follow-up assessments, the study aims to shed light on the impact of Retrograde Inferior Vena Cava Perfusion (RIVP) during Acute Type A Aortic Dissection (ATAAD) repair on gastrointestinal (GI) complications and systemic/intestinal inflammation. The integration of specialized Case Report Forms (CRFs) and structured questionnaires ensures standardized data collection and management, while prioritizing patient confidentiality. The study's data analysis, powered by R software, will provide valuable insights into the efficacy of Retrograde Inferior Vena Cava Perfusion (RIVP) in enhancing clinical outcomes and improving patient's prognosis in the surgical treatment of Acute Type A Aortic Dissection (ATAAD).
Conditions
- Type A Aortic Dissection
Interventions
- PROCEDURE
-
Retrograde Inferior Vena Cava Perfusion
Retrograde inferior vena cava (RIVP) involves perfusing oxygenated blood into the inferior vena cava, which then flows towards the viscera, abdominal organs and lower extremities. By maintaining perfusion to these regions during cardiopulmonary bypass (CPB) and induced hypothermia, Retrograde inferior vena cava (RIVP) helps mitigate the risk of ischemic injury to the abdominal organs. Following the initiation of total cardiopulmonary bypass, the body temperature will be gradually lowered to achieve deep-moderate hypothermia ( 24-38°C). This procedure will involve the combination of selective antegrade cerebral perfusion and retrograde inferior vena cava perfusion. Antegrade perfusion will be maintained at a flow rate of 5-7mL/min/kg, while retrograde perfusion will be regulated to sustain the required pumm pressure and blood flow.
- PROCEDURE
-
Antegrade cerebral perfusion
After mild to moderate hypothermia is achieved, a cannula will be inserted into the right axillary artery, brachiocephalic or innominate artery to provide continuous flow to the brain. A flow rate of 5-7mL/min/kg will be maintained.
Sponsors & Collaborators
-
The Second Hospital of Nanjing Medical University
lead OTHER
Principal Investigators
-
Qing Guo Li · The Second Hospital of Nanjing Medical University
-
Sanaa Azim · The Second Affiliate Hospital of Nanjing Medical University
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-25
- Primary Completion
- 2024-08-31
- Completion
- 2024-08-31
Countries
- China
Study Locations
More Related Trials
-
Cardiopulmonary Protective Effects of Modified Remote Ischaemic Preconditioning in Mitral Valve Replacement Surgery
NCT03010839 ·Status: COMPLETED ·Phase: NA
-
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation
NCT06381271 ·Status: RECRUITING
-
Safety and Feasibility of the Transcatheter Tricuspid Valve Repair System (Trialign)
NCT04936802 ·Status: UNKNOWN ·Phase: NA
-
Remote Ischemic Preconditioning With Postconditioning in Heart Transplantation Surgery
NCT02149316 ·Status: COMPLETED ·Phase: NA
-
Endovascular Aortic Repair for Aortic Dissection
NCT01505309 ·Status: UNKNOWN ·Phase: NA
-
Cardioprotective Effect of RIPC in Patients Undergoing TAVI
NCT02283398 ·Status: WITHDRAWN ·Phase: NA
-
Outcomes of Aortic Dissection Repair
NCT05927090 ·Status: ENROLLING_BY_INVITATION
-
Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI
NCT04281771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Safety of the Transcatheter Tricuspid Valvuloplasty System in Patients With Severe or Above Tricuspid Regurgitation
NCT05770648 ·Status: UNKNOWN ·Phase: NA
-
Beating Versus Arrested Heart for Mitral Valve Replacement
NCT01641614 ·Status: COMPLETED ·Phase: PHASE4
-
Mitral Valve Repair Combined Coronary Artery Bypass Grafting(CABG) Verus CABG Alone on Functional Ischemic Mitral Regurgitation
NCT03525041 ·Status: UNKNOWN ·Phase: NA
-
Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects
NCT00890799 ·Status: COMPLETED ·Phase: NA
-
Minimally Invasive Transthoracic Device Closure in Perimembranous Ventricular Septal Defect
NCT02644330 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Comparison of Tricuspid Replacement and Repair in Patients With Combined Heart Valve Disease
NCT01246141 ·Status: COMPLETED
-
Effect of Remote Ischemic Perconditioning on Acute Kidney Injury in Adult Valve Replace
NCT01476969 ·Status: UNKNOWN ·Phase: NA
-
Effect of Delayed Remote Ischemic Preconditioning on Myocardial Injury
NCT01903161 ·Status: COMPLETED ·Phase: NA
-
Real-World Prospective Parallel Controlled Study on Endovascular Therapy for Improving Perfusion and Remodeling of TBAD
NCT07022145 ·Status: NOT_YET_RECRUITING
-
Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation
NCT00624884 ·Status: COMPLETED
-
Transcatheter Aortic Valve Replacement With Extracorporeal Life System Support
NCT04160624 ·Status: UNKNOWN ·Phase: NA
-
Effects of Beta-adrenergic in Adults w/Transposition of Great Arteries on Systemic Ventricular Function
NCT00313352 ·Status: COMPLETED
-
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
NCT07267117 ·Status: RECRUITING
-
Effect of Remote Ischemia Preconditioning on Myocardial Injury in Patients Undergoing Heart Valve Surgery
NCT01175681 ·Status: COMPLETED ·Phase: NA
-
Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
NCT01403142 ·Status: COMPLETED
-
Blood Transfusion Management in Patients With Mitral Valve Replacement in China
NCT03885570 ·Status: UNKNOWN
-
Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery
NCT05632432 ·Status: RECRUITING ·Phase: NA